June 2025 in “British Journal of Dermatology” Nail abnormalities in children can indicate deeper health issues.
June 2025 in “British Journal of Dermatology” Syphilis can mimic other diseases, making diagnosis challenging, but proper testing and treatment are effective.
June 2025 in “British Journal of Dermatology” Frontal fibrosing alopecia can occur in men and may be linked to immune triggers like vaccines.
May 2025 in “International Journal of Trichology” Dutasteride mesotherapy can cause hair loss in some people.
March 2025 in “Canadian dermatology today.” Clascoterone cream 1% is effective and well-tolerated for treating acne and other related conditions.
February 2025 in “Medico Research Chronicles” Verilich hair serum significantly reduces hair shedding and is safe to use.
February 2025 in “International Research Journal of Modernization in Engineering Technology and Science” Jaborandi tincture mixed with coconut oil may reduce hair fall and improve scalp health.
February 2025 in “PubMed” Thorough scalp exams are crucial for diagnosing hair loss conditions in people with skin of color.
The treatment showed promising results in improving advanced-stage hair loss.
January 2025 in “Clinical Cosmetic and Investigational Dermatology” Clascoterone cream effectively reduces acne severity and is safe for patients 12 and older.
Spironolactone is generally safe and effective for treating hair loss in women, but may be less effective in severe cases.
January 2025 in “Open Veterinary Journal” Electrochemotherapy successfully treated skin tumors in cats without recurrence.
November 2024 in “Journal of Cosmetic Dermatology” MSC exosome therapy improved hair quality in patients with acquired trichorrhexis nodosa.
November 2024 in “SKIN The Journal of Cutaneous Medicine” The gummy improved hair growth and reduced shedding in women.
October 2024 in “JAAD Case Reports” Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.
September 2024 in “Electronic Journal of General Medicine” Diagnosing Sertoli-Leydig cell tumors is challenging due to their unusual symptoms and can occur at any age.
July 2024 in “Scholars Journal of Medical Case Reports” Combining low-level laser therapy and exosome therapy promotes hair growth.
Magnetized saline water may reduce chronic itching in elderly people.
June 2024 in “International Journal of Dermatology” Upadacitinib may effectively treat resistant lichen planopilaris.
Exosomes may be more effective than PRP for hair restoration.
March 2024 in “Authorea (Authorea)” Using lyopreserved umbilical tissue allograft may improve healing and reduce recurrence of pilonidal cysts.
March 2024 in “Clinical, cosmetic and investigational dermatology” Upadacitinib may effectively treat alopecia areata without side effects.
January 2024 in “International Journal of Homoeopathic Sciences” Individualized homeopathic treatment can effectively treat alopecia areata.
December 2023 in “Journal of dermatology” The study concluded that key signs of Keratosis follicularis spinulosa decalvans are changes in terminal hair and vellus hair follicles, which likely start the inflammation and damage to hair follicles.
November 2023 in “JAAD case reports” Exogenous testosterone use may be linked to developing hidradenitis suppurativa.
September 2023 in “International Journal of Trichology” Early treatment of Folliculitis Decalvans in children can improve inflammation and partially regrow hair.
September 2023 in “International Journal of Trichology” A rare hair regrowth pattern can occur in some people with alopecia areata.
August 2023 in “Clinical and experimental dermatology and therapies” Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.
June 2023 in “British Journal of Dermatology” Facial lichen planopilaris may be triggered by shaving and mustard oil, and early detection is crucial for better treatment outcomes.
May 2023 in “The Journal of Sexual Medicine” Flibanserin may help improve sexual symptoms in various conditions beyond its approved use.